These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 24642067)

  • 21. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
    Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotyping approach for non-invasive foetal RHD detection in an admixed population.
    Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM
    Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
    Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
    Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
    Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal RhD genotyping by analysis of maternal blood. A case report.
    Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
    J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A; Tounta G; Mavrou A
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
    Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving.
    Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM
    Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.
    Gordon LG; Hyland CA; Hyett JA; O'Brien H; Millard G; Flower RL; Gardener GJ
    Prenat Diagn; 2017 Dec; 37(12):1245-1253. PubMed ID: 29096422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
    Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
    Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
    Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
    BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
    Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
    Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
    Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
    Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
    Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
    Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive fetal RhD status determination in early pregnancy.
    Manzanares S; Entrala C; Sánchez-Gila M; Fernández-Rosado F; Cobo D; Martinez E; Molina L; Reche R; Pineda A; Gallo JL
    Fetal Diagn Ther; 2014; 35(1):7-12. PubMed ID: 24335165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multiplex PCR for non-invasive fetal RHD genotyping using cell-free fetal DNA.
    Tounta G; Vrettou C; Kolialexi A; Papantoniou N; Destouni A; Tsangaris GT; Antsaklis A; Kanavakis E; Mavrou A
    In Vivo; 2011; 25(3):411-7. PubMed ID: 21576416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
    Cardo L; García BP; Alvarez FV
    Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.